Apr 17 |
Biotech Leader Intra-Cellular Soars 23%, Breaks Out Past Latest Buy Point
|
Apr 17 |
Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
|
Apr 17 |
Intra-Cellular (ITCI) Moves 23.3% Higher: Will This Strength Last?
|
Apr 17 |
Abbott Laboratories, U.S. Bancorp And 3 Stocks To Watch Heading Into Wednesday
|
Apr 16 |
Intra-Cellular Therapies announces proposed public offering of common stock
|
Apr 16 |
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
|
Apr 16 |
Intra-Cellular: More Upside Possible Even After Positive MDD Treatment Data
|
Apr 16 |
UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday
|
Apr 16 |
Intra-Cellular Therapies Stock Launches 20% Into Breakout Territory On Depression Test Results
|
Apr 16 |
Intra-Cellular Therapies gains on meeting main goal in trial for its depression treatment
|